Position in INCY
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$1,541,403
+$212,453 QoQ
Shares Held
16,377
+21.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sequoia Financial Advisors, LLC holds $24,441,881 across 36 Biotechnology names. INCY ranks #4 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
14,898 | $6,652,552 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,189 | $2,463,948 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
175,917 | $1,657,138 | |
| 4 | INCY |
Incyte Corp
This page
|
16,377 | $1,541,403 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,560 | $1,508,767 | |
| 6 | ARGX |
Argenx SE
|
1,961 | $1,432,020 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
4,138 | $782,288 | |
| 8 | RPRX |
Royalty Pharma plc
|
15,670 | $751,689 |
All Filings in INCY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,541,403 | 16,377 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,328,950 | 13,455 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $861,160 | 10,154 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $471,456 | 6,923 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $285,735 | 4,719 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $339,962 | 4,922 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $299,234 | 4,527 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $268,667 | 4,432 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $236,140 | 4,145 | Shares | Sole | 2024-04-30 | |
| 2023-06-30 | $219,493 | 3,526 | Shares | Sole | 2023-08-08 | |
| 2022-12-31 | $206,663 | 2,573 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $265,819 | 3,499 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $393,605 | 4,956 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $496,551 | 6,765 | Shares | Sole | 2022-02-22 | |
| 2021-09-30 | $1,754,440 | 25,508 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $6,452,266 | 76,694 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $5,441,270 | 66,953 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,709,976 | 65,647 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,239,380 | 58,384 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $5,311,411 | 51,086 | Shares | Sole | 2020-08-25 | |
| 2020-03-31 | $4,027,576 | 54,999 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||